Analysis of Personality Traits in Patients with Hodgkin Lymphoma.

Hodgkin lymphoma five-factor model health outcomes inflammatory biomarkers maladaptive traits mental disorders personality traits

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
12 Apr 2021
Historique:
received: 25 01 2021
revised: 22 03 2021
accepted: 08 04 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 1 5 2021
Statut: epublish

Résumé

Hodgkin lymphoma (HL) is a highly-curable malignancy mostly affecting young people. As far as we know, there is no published study that has analyzed personality profiles in HL nor their potential role in lymphomagenesis, natural history, or response to treatment. We aim to explore the personality traits of HL patients, as well as the prevalence of mental disorders and suicide ideas. We retrospectively identified all alive HL patients from three centers (Son Espases and Son Llatzer University Hospitals and Hospital del Mar of Barcelona) for using NEO Five-Factor Inventory (NEO-FFI) and Personality Inventory for DSM-5 Brief Form. Patients with HL showed significantly higher neuroticism scores and lower conscientiousness, extraversion, and openness. Considering maladaptive personality traits, HL patients showed higher levels of detachment and psychoticism. All of these translated into the fact that HL patients showed more than double the prevalence of mental illnesses (41%) and more than triple the prevalence of suicidal ideation or attempts than the general population (15 and 6%, respectively). An exploratory analysis of biomarkers associated with HL personality traits showed that higher scores of neuroticism correlated with more elevated erythrocyte sedimentation rate (ESR) and red cell distribution width (RDW), suggesting a potential link between neuroticism and proinflammatory activity in HL.

Identifiants

pubmed: 33921383
pii: jcm10081631
doi: 10.3390/jcm10081631
pmc: PMC8069925
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Pers Assess. 2014;96(5):532-43
pubmed: 24837586
Front Psychiatry. 2019 Nov 12;10:819
pubmed: 31798472
Psychol Rep. 2018 Apr;121(2):344-355
pubmed: 28799886
Span J Psychol. 2012 Jul;15(2):756-67
pubmed: 22774449
Eur J Pers. 2018 May-Jun;32(3):151-166
pubmed: 30140117
Gac Sanit. 2020 Mar - Apr;34(2):114-119
pubmed: 31053452
J Affect Disord. 2019 Mar 1;246:408-417
pubmed: 30597303
J Clin Oncol. 1988 Apr;6(4):596-602
pubmed: 3357004
J Affect Disord. 2014 Jul;163:1-9
pubmed: 24836081
Eur J Breast Health. 2018 Apr 01;14(2):105-111
pubmed: 29774319
Psychol Med. 2012 Sep;42(9):1879-90
pubmed: 22153017
Psychiatry Clin Neurosci. 2010 Aug;64(4):435-41
pubmed: 20653910
Cancers (Basel). 2020 Nov 04;12(11):
pubmed: 33158258
J Pers Assess. 2016 Jul-Aug;98(4):351-9
pubmed: 27049169
Psychol Med. 2010 Sep;40(9):1485-93
pubmed: 19995479
Bone Marrow Transplant. 2013 Jan;48(1):129-34
pubmed: 22609882
Annu Rev Psychol. 2019 Jan 4;70:423-448
pubmed: 30231002
J Pers. 2014 Dec;82(6):493-501
pubmed: 23998798
J Psychosom Res. 2012 Aug;73(2):98-103
pubmed: 22789411
J Pers. 1992 Jun;60(2):175-215
pubmed: 1635039
Med Clin (Barc). 2006 Apr 1;126(12):445-51
pubmed: 16620730
Assessment. 2017 Apr;24(3):326-336
pubmed: 26391204
Assessment. 2013 Jun;20(3):312-26
pubmed: 23596272
J Clin Psychiatry. 2007;68 Suppl 2:3-9
pubmed: 17288501
J Pers. 2017 Apr;85(2):220-231
pubmed: 26691245
Psychosom Med. 2008 Jul;70(6):621-7
pubmed: 18596250
Personal Disord. 2020 Nov;11(6):409-417
pubmed: 31855004
Med Clin (Barc). 2007 Oct 13;129(13):494-500
pubmed: 17980118
Arch Pathol Lab Med. 2009 Apr;133(4):628-32
pubmed: 19391664
Clin Nutr. 2010 Oct;29(5):600-4
pubmed: 20334961
Pers Individ Dif. 2017 Oct 15;117:130-138
pubmed: 29479128
Health Psychol. 2011 Sep;30(5):536-41
pubmed: 21604882
Psychooncology. 2020 Jun;29(6):1060-1067
pubmed: 32154960
Acta Oncol. 2009;48(6):842-9
pubmed: 19412812
Future Oncol. 2010 May;6(5):691-707
pubmed: 20465385
Pers Soc Psychol Bull. 2006 Aug;32(8):999-1009
pubmed: 16861305
Am Psychol. 2009 May-Jun;64(4):241-56
pubmed: 19449983
Br J Cancer. 2006 Jul 17;95(2):146-52
pubmed: 16819543
Annu Rev Psychol. 2005;56:453-84
pubmed: 15709943
J Pers Assess. 1997 Apr;68(2):228-50
pubmed: 16370779
Psychol Assess. 2017 Apr;29(4):473-478
pubmed: 27414150
Ann Behav Med. 2013 Jun;45(3):278-88
pubmed: 23225322
J Health Psychol. 2019 Sep;24(11):1494-1504
pubmed: 29355050

Auteurs

Fatima Roso-Bas (F)

Clinical Practice and Biology of the Hematological Malignancies Research Group, IdISBa, Son Espases University Hospital, 07120 Palma de Mallorca, Spain.

Maria Dolores Alonso-Llobregat (MD)

Clinical Practice and Biology of the Hematological Malignancies Research Group, IdISBa, Son Espases University Hospital, 07120 Palma de Mallorca, Spain.

Leyre Bento (L)

Clinical Practice and Biology of the Hematological Malignancies Research Group, IdISBa, Son Espases University Hospital, 07120 Palma de Mallorca, Spain.
Unit of Lymphoma, Department of Hematology, Son Espases University Hospital, 07120 Palma de Mallorca, Spain.

Blanca Sanchez-Gonzalez (B)

Department of Hematology, Hospital del Mar, 08003 Barcelona, Spain.
IMIM, Hospital del Mar Research Institute, 08003 Barcelona, Spain.

Ines Herraez (I)

Clinical Practice and Biology of the Hematological Malignancies Research Group, IdISBa, Son Espases University Hospital, 07120 Palma de Mallorca, Spain.
Department of Hematology. Son Llatzer University Hospital, 07120 Palma de Mallorca, Spain.

Pilar Garcia-Dilla (P)

Department of Hematology, Hospital del Mar, 08003 Barcelona, Spain.

Catalina Vallespir (C)

Service of Psychiatry, Son Espases University Hospital, 07120 Palma de Mallorca, Spain.

Francesca Rado (F)

Service of Psychiatry, Son Espases University Hospital, 07120 Palma de Mallorca, Spain.

Raquel Rodriguez (R)

Psychosocial Support Team, Son Llatzer University Hospital, 07198 Palma de Mallorca, Spain.

Francesc Garcia-Pallarols (F)

Department of Hematology, Hospital del Mar, 08003 Barcelona, Spain.

Irache Aguirre (I)

Service of Psychiatry, Son Espases University Hospital, 07120 Palma de Mallorca, Spain.

Joan Bargay (J)

Clinical Practice and Biology of the Hematological Malignancies Research Group, IdISBa, Son Espases University Hospital, 07120 Palma de Mallorca, Spain.
Department of Hematology. Son Llatzer University Hospital, 07120 Palma de Mallorca, Spain.

Antonia Sampol (A)

Clinical Practice and Biology of the Hematological Malignancies Research Group, IdISBa, Son Espases University Hospital, 07120 Palma de Mallorca, Spain.

Antonio Salar (A)

Department of Hematology, Hospital del Mar, 08003 Barcelona, Spain.
IMIM, Hospital del Mar Research Institute, 08003 Barcelona, Spain.

Antonio Gutierrez (A)

Clinical Practice and Biology of the Hematological Malignancies Research Group, IdISBa, Son Espases University Hospital, 07120 Palma de Mallorca, Spain.
Unit of Lymphoma, Department of Hematology, Son Espases University Hospital, 07120 Palma de Mallorca, Spain.

Classifications MeSH